Current role
Jonathan Quick
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jonathan Quick
Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Jonathan Quick was appointed the Company's Senior Vice President, Finance and Treasurer, effective April 28, 2025.
“On April 28, 2025, the Board appointed Tom Frohlich as the Company's Chief Executive Officer, Jonathan Quick as the Company's Senior Vice President, Finance and Treasurer, Andrew King as the Company's Chief Scientific Officer & Head of Research and Development, Hetal Kocinsky as the Company's Chief Medical Officer and Elizabeth Balta as General Counsel and Corporate Secretary, each to serve at the discretion of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Jade Biosciences, Inc. (JBIO)
SEC 8-K
Current2025-04-28–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Jade Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Tom Frohlich CEO, Board Member
- Eric Dobmeier Chairman, Board Member
- Bradford Dahms CFO
- Andrew King CTO
- Elizabeth Balta General Counsel
- Christopher Cain Board Member
- Continuing Directors Board Member
- Donald J. Santel Board Member
- Erin Lavelle Board Member
- Habib J. Dable Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.